Why the body site matters
This result often appears on an organic-acids or yeast panel. A high number is sometimes called proof of an intestinal infection, even though it cannot show an infected body site. Check the exact test, sample, kidney function, and symptoms. Then use an exam, culture, or blood test made for the body site in question.
The urine cannot name the body site
The urine cannot show where Candida is
A high result cannot tell mouth, skin, vaginal, urinary, small-intestinal, blood, or deep-organ illness apart. Each site needs its own test.
Who researchers studied
Most studies involved people at high risk
Older studies focused on serious Candida infection in people with neutropenia, cancer, HIV, kidney disease, or a hospital stay, and in newborns. They did not study stable adults with long-term bloating and brain fog.
Use the lab's range
One range cannot fit every test
A result for D-arabinitol alone, a result corrected for creatinine, and a D/L ratio use different methods and units. Kidney function and urine concentration also matter.
Use an exam, culture, or blood test made for the suspected site. Do not choose antifungal treatment or a strict diet from this urine result.
Save this test
Save the exact assay, result, and reason it was ordered
Save the result with the body site, kidney tests, infection risks, medicines, and the test that will confirm the cause.
My Fog keeps the report and notes you enter for your appointment.
Age, sex, pregnancy, immune risk, kidney function, and the suspected body site
Start with the range for the exact test. Age, body site, pregnancy, kidney function, immune health, diabetes, medicines, and a recent hospital stay change which Candida illness and follow-up test make sense.
Babies, children, and teenagers
Very early or very small newborns can get a serious Candida infection in the hospital. Urine-ratio studies included some newborns and children, but this is not a home screen. A baby or child with fever, poor feeding, unusual sleepiness, trouble breathing, or serious illness needs medical care now.
Women and vaginal symptoms
Itching, soreness, pain, or discharge can come from yeast, another infection, or a skin problem. A clinician may need to examine the area and test a local sample. Urine D-arabinitol cannot identify the cause.
Pregnancy and postpartum
Pregnancy changes which antifungal drugs are safe. Vaginal symptoms still need a local exam or sample. Ask the pregnancy team before using an oral or vaginal treatment while pregnant or breastfeeding.
Men and local symptoms
Symptoms on the penis, groin, mouth, skin, throat, or urinary tract need an exam and a test from that site. There is no separate D-arabinitol brain-fog target for men.
Immune suppression and hospital risk
A serious Candida infection is more likely with neutropenia, cancer care, transplant, critical illness, a central line, or broad antibiotics. Belly surgery, IV feeding, dialysis, and very early birth can also raise the risk. Fever, chills, low blood pressure, confusion, or fast decline needs urgent medical tests.
Older adults and kidney disease
Kidney failure, dialysis, diabetes, a recent hospital stay, catheters, antibiotics, dentures, dry mouth, and many medicines can change infection risk. Save creatinine and eGFR for the clinician. Do not use them to set your own treatment cutoff.
Before collecting the sample
Check which test you're getting: D-arabinitol alone, D-arabinitol divided by creatinine, a D/L ratio, or one part of an organic-acids panel. You can't compare these results as if they were the same test.
Follow the kit's rules for collecting and shipping urine. Save the collection time, whether it was the first urine of the morning, how it was kept cold, and any shipping delay.
Ask whether to eat and drink as usual. Do not fast, limit water, eat extra sugar, or change carbohydrates to alter the result unless the lab and clinician tell you to.
Bring every medicine and supplement. Include antibiotics, antifungals, steroids, immune medicines, diabetes medicines, probiotics, and herbs. Keep taking prescribed medicine unless the prescriber tells you to change it.
Save creatinine, eGFR, dialysis details, and whether the urine was very watery or concentrated. Kidney function and urine concentration can change how the number is compared.
Confirm which body site needs checking: mouth, throat, vagina, skin, urine, blood, a deep organ, or the small intestine. Each site needs a different test.
Identify the exact test
Copy the sample type, method, value, unit, lab range, creatinine correction, and whether D- and L-arabinitol have separate results. Do not compare a urine number with a blood ratio or a range found online.
Name the body site
Urine D-arabinitol cannot show whether Candida is in the mouth, vagina, skin, urine, small intestine, blood, or a deep organ. Ask which exam or sample can check the suspected site.
Check your risk of a serious infection
Most research did not study healthy people with long-term brain fog. Record whether you were very ill, in the hospital, had a weak immune system, or had signs of infection at one body site.
Ask what the result will change
Before a repeat test or treatment, ask whether the result leads to an exam, culture, blood test, blood sugar check, medicine review, or referral. If not, keep the report and continue the wider workup.
How to read a D-arabinitol result
First check the sample and method. Then check the unit, lab range, ratio or creatinine correction, kidney function, urine concentration, body site, and infection risk.
Within the assay interval
Within the performing laboratory's interval for that exact urine assay or ratio
This test did not find a high D-arabinitol result. Use a local exam or sample for symptoms in the mouth, skin, vagina, or urinary tract. A very sick or high-risk person may need urgent blood and site tests.
Hard to compare or collection-limited
Near the laboratory cutoff, difficult to compare, or limited by unclear method, missing creatinine correction, dilute urine, kidney dysfunction, recent treatment, or collection problems
First check the original report, kidney function, sample handling, medicines, infection risk, and suspected body site. Ask whether the right confirming test is available before treating an infection.
Elevated and needs the right confirmation
Above the performing laboratory's interval or an elevated D/L-arabinitol or D-arabinitol-to-creatinine ratio
The marker was high, but it did not show where Candida is. A very sick person or someone with a weak immune system may need urgent cultures and blood tests. A stable person with long-term gut symptoms should first confirm which illness and body site are in question.
Different Candida illnesses need different tests
CDC guidance uses an exam or local sample for mouth, vaginal, and skin symptoms. A serious Candida infection may need blood or infected-site cultures. SIFO research uses a small-bowel sample. Its 10³ fungal CFU/mL cutoff does not apply to urine.
See research details
These notes explain the older hospital research, lab methods, kidney effects, and SIFO tests.
Keep those numbers inside that gas-chromatography method and study population. They are not a universal modern urine cutoff.
Results from a test that worked differently in people with neutropenia don't apply to ordinary fatigue, bloating, or brain fog without proof.
An unwell newborn or premature infant needs pediatric and hospital assessment. Do not use a home specialty result to reassure or treat.
If urinary infection is suspected, ask for the urinary examination and culture pathway rather than inferring it from a commercial metabolite line.
Use D-arabinitol as neither a shortcut nor a substitute for a gastroenterology discussion when SIFO is the actual question.
Keep looking into sleep, CBC and ferritin, B12 and folate, thyroid, glucose, kidney and liver function, medicines, migraine, infection, mood, and symptoms on standing during a proper Candida check.
What can you do before follow-up?
Confirm which body site and symptoms need checking. Follow the sample rules and keep your usual food and water intake unless the clinic says otherwise.
Body site and timing
Write where symptoms occur and when they began. Add recent antibiotics or steroids, blood sugar changes, hospital stays, surgery, catheters, immune treatment, local exam or culture results, and treatments already tried.
Keep ordinary food and fluid intake
Do not limit water, fast, eat extra sugar, or follow a strict Candida diet to change the result. Eat regular meals that fit your health needs. Note major diet changes because weight loss and too little food can also cause tiredness and poor focus.
Review glucose when infections recur
Repeated yeast infections may be a reason to check diabetes risk or blood sugar control. Keep taking diabetes medicine as prescribed. Use standard blood sugar tests for this question.
Ask for the confirming route
Ask which exam, swab, microscope test, culture, blood test, or scan can confirm infection at the suspected site. For long-term gut symptoms, ask what else to check before a small-bowel sample for fungal overgrowth.
Do not start or extend antifungal drugs, boric acid, herbs, binders, cleanses, enemas, fasting, extra sugar, or a strict Candida diet from this result. Get urgent care for fever or chills with a weak immune system, cancer care, transplant, a central line, recent major belly surgery, or dialysis. Very low blood pressure, fainting, confusion, trouble breathing, severe weakness, repeated vomiting, a very sick newborn, or fast decline also needs urgent care.
What to save before the next appointment
Keep these together
- Laboratory, panel name, urine or serum specimen, method, D-arabinitol value, unit, laboratory interval, D/L ratio, and creatinine correction.
- Collection date and time, first-morning or random sample, urine concentration, refrigeration, freezing, shipping delay, and any rejected or questionable sample note.
- Serum creatinine, eGFR, dialysis, diabetes or glucose results, recent hospitalization, operation, catheter, parenteral nutrition, cancer treatment, transplant, or neutropenia.
- The suspected body site, exact symptoms, local examination, swab, microscopy, culture, blood culture, imaging, and any previous Candida species or susceptibility result.
- Recent antibiotics, steroids, immune medicines, antifungals, probiotics, herbal products, diet changes, clinician interpretation, and what the result is supposed to change.
Question for the visit
“Ask which body site the result is meant to check, what test can confirm infection there, and whether repeating D-arabinitol would change care.”
Sources for D-Arabinitol Urine Test
Guide sections: Brain fog needs its own workup; Women and vaginal symptoms; Pregnancy and postpartum; Men and local symptoms; Body site and timing; Ask for the confirming route
Guide sections: Newborn evidence is a hospital pathway; Babies, children, and teenagers; Immune suppression and hospital risk; Older adults and kidney disease; Body site and timing
Guide sections: Review glucose when infections recur
Guide sections: Brain fog needs its own workup
Gas chromatographic determination of D-arabinitol/L-arabinitol ratios in urine: a potential method for diagnosis of disseminated candidiasis.
Detection of candidaemia in patients with and without underlying haematological disease.
Urine D-arabinitol/L-arabinitol ratio in diagnosis of invasive candidiasis in newborn infants.
D-arabinitol--a marker for invasive candidiasis.
Measurement of the D-arabinitol/L-arabinitol ratio in urine of neutropenic patients treated empirically with amphotericin B.
Urine D-arabinitol/L-arabinitol ratio in diagnosing Candida infection in patients with haematological malignancy and HIV infection.
D-arabinitol versus mannan antigen and candidal protein antigen as a serum marker for Candida pyelonephritis.
Diagnosis of disseminated candidiasis based on serum D/L-arabinitol ratios using negative chemical ionization mass spectrometry.
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives.
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives.
See each claim's sources
indication
D-arabinitol and D/L-arabinitol ratios have mainly been studied as adjunct markers in invasive-candidiasis populations, including hospitalized, neutropenic, cancer, HIV, and newborn groups.range
A 1994 gas-chromatography study reported urine D/L-arabinitol ratios of 1.1 to 4.5 among 96 people without signs of deep Candida infection and values up to 19.0 in one disseminated-candidiasis case; this is method-specific research, not a universal cutoff.interpretation
A 2010 candidemia study reported 41.7 percent sensitivity and 86.4 percent specificity overall for serum D/L-arabinitol, with 75 percent sensitivity and 90.5 percent specificity in a hematologic-neutropenia subgroup.interpretation
Kidney function, urine concentration, specimen type, and whether the laboratory reports a D/L-arabinitol or creatinine-corrected ratio affect interpretation.limitation
A specialty urine D-arabinitol result does not locate Candida or replace the body-site examination, local sample, blood culture, or sterile-site culture used for the suspected form of candidiasis.limitation
Urine D-arabinitol is not a validated SIFO diagnosis; a 2025 review describes distal-duodenal or jejunal aspirate culture with a commonly used but arbitrary threshold of at least 10³ fungal CFU/mL.limitation
Current CDC guidance primarily diagnoses invasive candidiasis with blood culture, while IDSA describes cultures plus selected nonculture adjuncts interpreted in high-risk clinical context.limitation
The available D-arabinitol studies do not validate a commercial urine result as a diagnosis of the cause of ordinary brain fog or show that lowering the number improves cognition.context
Major invasive-candidiasis risk factors include critical illness, central venous catheters, broad-spectrum antibiotics, parenteral nutrition, malignancy, neutropenia, transplant, abdominal surgery, renal failure or dialysis, and very premature birth.safety
Antifungal treatment should not be selected from a specialty D-arabinitol result alone because diagnosis, body site, species, susceptibility, pregnancy, medicines, and kidney or liver safety affect the decision.